Loss of adipose triglyceride lipase is associated with human cancer and induces mouse pulmonary neoplasia.
Ontology highlight
ABSTRACT: Metabolic reprogramming is a hallmark of cancer. Understanding cancer metabolism is instrumental to devise innovative therapeutic approaches. Anabolic metabolism, including the induction of lipogenic enzymes, is a key feature of proliferating cells. Here, we report a novel tumor suppressive function for adipose triglyceride lipase (ATGL), the rate limiting enzyme in the triglyceride hydrolysis cascade.In immunohistochemical analysis, non-small cell lung cancers, pancreatic adenocarcinoma as well as leiomyosarcoma showed significantly reduced levels of ATGL protein compared to corresponding normal tissues. The ATGL gene was frequently deleted in various forms of cancers. Low levels of ATGL mRNA correlated with significantly reduced survival in patients with ovarian, breast, gastric and non-
SUBMITTER: Al-Zoughbi W
PROVIDER: S-EPMC5085122 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA